SAN DIEGO, CA – CureMatch is pleased to announce it has been selected to take part in MetroConnect 2017, an export assistance program run by the World Trade Center San Diego (WTC) and designed to help San Diego companies accelerate their global growth. The announcement will be made today by San Diego Mayor Kevin Faulconer and WTC San Diego.
An article appeared in today's Coast News which chronicles Blaise Barrelet's journey from cancer patient to CureMatch CEO, and shares that the CureMatch personalized medicine approach is online and ready. Actionable insights based upon genomics are now available to the best oncologists across the country to quickly match up combination drug treatments using the most in-depth custom curated databases of drugs and cancer mutations available.
The goal is to accelerate the adoption of genomics and combination therapy in oncology to increase standard of care for cancer patients SAN DIEGO, CA – March 30, 2017 – CureMatch, the developer of a decision support system for personalized combination therapy for cancer, and Patient Power, an online news source for cancer patients, today […]
